Has Amy Whistler received payments from drug or device companies?

Yes. Drug and device makers reported $6,806 in general payments to Amy Whistler across 376 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Whistler did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Whistler come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Whistler

Psychiatric/Mental Health · Gainesville, FLNPI 1942683016

Payments from drug & device makers

$6,806in general payments, 2019–2025

Across 376 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$981
Teva Pharmaceuticals USA, Inc.$694
Neurocrine Biosciences, Inc.$536
Otsuka America Pharmaceutical, Inc.$517
Vanda Pharmaceuticals Inc.$508
plus $2K from 14 others

What the payments were for

Food & beverage$6,75999%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	105	$1,274
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	32	$981
Teva Pharmaceuticals USA, Inc.	27	$694
Neurocrine Biosciences, Inc.	24	$536
Otsuka America Pharmaceutical, Inc.	29	$517
Vanda Pharmaceuticals Inc.	20	$508
Johnson & Johnson	12	$468
Sunovion Pharmaceuticals Inc.	44	$404
Lundbeck LLC	26	$401
Alkermes, Inc.	11	$219
Indivior Inc.	12	$200
Axsome Therapeutics, Inc.	10	$169
Takeda Pharmaceuticals U.S.A., Inc.	8	$148
Gilead	4	$78
Tris Pharma Inc	3	$55
Idorsia Pharmaceuticals US Inc	3	$48
Avanir Pharmaceuticals, Inc.	2	$45
Corium, LLC	2	$35
Supernus Pharmaceuticals, Inc.	1	$15
Eisai Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,806 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	12	$19,700
VivitrolNaltrexone Microspheres	11	$19,085
Olanzapine	14	$775
Hydroxyzine Hcl	20	$523
Trazodone Hcl	27	$309
Buspirone Hcl	12	$282
Prazosin Hcl	19	$201
Lamotrigine	13	$106
Escitalopram Oxalate	13	$24

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$1,274	$19,70012 claims
Alkermes, Inc.Vivitrol	$219	$19,08511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Gainesville

Linda SkalskyGainesville$53K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →